Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2019 · 10-Q
Revenue$703.00K$703.00K−3.8% vs Q1 2018 Net Income-$3.15M-$3.15MN/M vs Q1 2018 EPS Diluted-$8.92-$8.92N/M vs Q1 2018 Operating Income-$2,166,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,276,000N/M Margins · derivedOperating margin-308.1%+287.2 pt vs Q1 2018
Net margin-448.1%+155.1 pt vs Q1 2018
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end